Veterinary Support
Need to report a suspected adverse event or lack of expected efficacy?
You can save time by using our simple online pharmacovigilance reporting portal.
Knowledge Hub
Our Knowledge Hub is designed to answer the majority of FAQs our Veterinary Services Vets receive. Find the widget in the bottom right-hand corner of the screen – click it to open the Knowledge Hub and search for your topic.
Is your enquiry more urgent?
If you would like product advice or a clinical case discussion, you can access Live Chat in our Knowledge Hub. Find the widget in the bottom right-hand corner of the screen, and you can choose to start a conversation with one of our Technical Services Vets. Available during service hours.
We know that it’s important that you know you’re speaking to a ‘real’ person. After you’ve answered a few questions from our chatbot, your enquiry will be transferred to one of our Technical Services Vets.
We understand that you may be in between consults or surgery, so you can return to the chat until your enquiry is resolved, for up to 72 hours. You can access chat on the web browser on both your smartphone and desktop.
Downloadable content
We have a range of downloadable content for you.
Vet Management Guide
The Vet Management Guide provides all you need to know about managing diabetes in cats with Senvelgo®
Cat owner leaflet
The cat owner leaflet provides a wealth of information and advice for your clients that have been prescribed Senvelgo®
Homecare Journal
The Homecare Journal enables your clients to monitor their cats health and ketones at home
User Experience Study
Vets who have used Senvelgo® highly recommended it awarding a score of 8.7 out of 10. Discover what vets and owners are saying about treating cats with Senvelgo®
-
1. Niessen, S. J. M. et al. (2022) Once daily oral therapy for feline diabetes mellitus: evaluation of SGLT-2 inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats. Journal of Veterinary Internal Medicine 36, 2512–2513.
-
2. Sparkes, A. H. et al. (2015) ISFM Consensus Guidelines on the Practical Management of Diabetes Mellitus in Cats. J Feline Med Surg 17, 235–50.
-
3. McCann, T., et al. (2007) Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Feline Med Surg 9, 289–9.
-
4. O’Neill, D., et al. (2016) Epidemiology of Diabetes Mellitus among 193,435 Cats Attending Primary-Care Veterinary Practices in England. J Vet Intern Med 30, 964–72.
-
5. Rand J, Gottlieb, SA. Feline diabetes mellitus. Textbook of Veterinary Internal Medicine, 8th edition. Ettinger SJ, Feldman EC and Cote E, eds. Elsevier, Missouri. 2017;1781-1795.
-
6. 2018 Summary of the Veterinary Clinic: Pet Obesity Prevalence Survey & Pet Owner: Weight Management, Nutrition, and Pet Food Survey. Available at:
https://petobesityprevention.org/2018. -
7. Niessen, S. J. M. et al. (2017) The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia. Vet Sci 4, 27.
-
8. Diabetes in Cats: Quantitative market research study. Proprietary presentation, July 19, 2021. Kynetec; St. Louis, MO, on behalf of Boehringer Ingelheim.
-
9. Niessen, S. J. M. et al. (2010) Evaluation of a quaility-of-life tool for cats with diabetes mellitus. J Vet Intern Med 24, 1098-105.
-
10. Behrend, E. N. et al. (2023) Velagliflozin, an SGLT2 Inhibitor, as a once-daily, oral solution, stand-alone therapy for feline diabetes mellitus. Oral abstract presentation, 2023 ACVIM Forum, Pennsylvania, Jun 15-17.
-
11. Niessen, S. J. M. et al. (2023) Efficacy and safety of once daily oral sodium-glucose co-transporter-2-inhibitor velagliflozin compared to twice daily insulin injection therapy in diabetic cats. Oral abstract presentation, 2023 ECVIM-CA Forum, Barcelona, Sept 21-23.
-
12. VMD. Summary of Product Characteristics (SPC): Senvelgo® 15mg/ml oral solution for cats (velagliflozin). Veterinary Medicines Directorate, UK.
-
13. CM Research (2022) Small animal vets UK April 2022. Syndicated Sales Rep Survey.